Abstract:Background and aims: Gallstone disease affects ≥40 million people in the USA and accounts for health costs of ≥$4 billion a year. Risk factors such as obesity and metabolic syndrome are well established. However, data are limited on relevant metabolomic alterations that could offer mechanistic and predictive insights into gallstone disease. This study prospectively identifies and externally validates circulating prediagnostic metabolites associated with incident gallstone disease. Methods: Female participants in Nurses' Health Study (NHS) and Nurses' Health Study II (NHS II) who were free of known gallstones (N=9960) were prospectively followed up after baseline metabolomic profiling with liquid chromatography-tandem mass spectrometry. Multivariable logistic regression and enrichment analysis were used to identify metabolites and metabolite groups associated with incident gallstone disease at PFDR<0.05. Findings were validated in 1866 female participants in the Women's Health Initiative and a comparative analysis was performed with 2178 male participants in the Health Professionals Follow-up Study. Results: After multivariate adjustment for lifestyle and putative risk factors, we identified and externally validated 17 metabolites associated with incident gallstone disease in women-nine triacylglycerols (TAGs) and diacylglycerols (DAGs) were positively associated, while eight plasmalogens and cholesterol ester (CE) were negatively associated. Enrichment analysis in male and female cohorts revealed positive class associations with DAGs, TAGs (≤56 carbon atoms and ≤3 double bonds) and de novo TAG biosynthesis pathways, as well as inverse associations with CEs. Conclusions: This study highlights several metabolites (TAGs, DAGs, plasmalogens and CE) that could be implicated in the aetiopathogenesis of gallstone disease and serve as clinically relevant markers.

Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis.

Gallstones And Risk Of Coronary Heart Disease: Prospective Analysis Of 270000 Men And Women From 3 Us Cohorts And Meta-Analysis

Gallstones and Risk of Coronary Heart Disease

Gallstone Disease and Increased Risk of Mortality: Two Large Prospective Studies in US Men and Women

Gallstones and Risk of Cancers of the Liver, Biliary Tract and Pancreas: a Prospective Study Within Two U.S. Cohorts

Bridging Three Years of Insights: Examining the Association Between Depression and Gallstone Disease

Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study

Gallstone Disease and the Risk of Ischemic Heart Disease

Hepatitis C Virus Infection is Positively Associated with Gallstones in Liver Cirrhosis.

Association between metabolic syndrome and gallstone disease

Depression increases the risk of gallstone: A cross-sectional study and Mendelian randomization analysis

Helicobacter Pylori Infection is Associated with Gallstones: Epidemiological Survey in China.

The Association between Gallstone Disease and Incidence of Cardiovascular Disease: A Systematic Review and Meta-Analysis

The relation between gallstone disease and cardiovascular disease

Gallstone disease is associated with an increased risk of inflammatory bowel disease: results from three prospective cohort studies

Metabolomic profiles of incident gallstone disease

Impact of gallstone disease on the risk of stroke and coronary artery disease: evidence from prospective observational studies and genetic analyses

Gallstone disease is associated with rectal cancer: a meta-analysis

The effect of cholecystectomy on the risk of colorectal cancer: A systematic review and meta-analysis

The Association Between Gallstone Disease and Metabolic Syndrome Related Abnormalities: a Systematic Review and Meta-Analysis

Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses